@apexalphatrading: 25/09: Moderna is up 220% in five weeks. That's not a rerating.. that's a short squeeze. 17% of the float was short. Phase 3 cancer data hit. Shorts had to buy at any price. Here's what a squeeze looks like and why it matters for anyone holding this now. Join Apex.. link in bio #mrna #cancer #stocks #trading #imvesting

shark91110 :

will short more on Monday.

Star :

retail are insane. The power they have on a single stocks is nuts.

googledme :

wise advice

mrpt89 :

So where are the “Semis” armagedon videos?🙄😂

Jack :

Do you think the new PYPL takeover rumours are real or nonsense.

civilisation1 :

MRNA only lose money currently

Invest&earn :

Great stuff👍👍

Brox :

BuildUpYourWealth :

Platform, pipeline and patent. That’s why Moderna can work. But patience has to feature, it’s biotech. I’m long, was long from $50, and I’ll still be long if it goes down in the elevator back

Nicole :

I’m not sure what to do with my shares. I’m at $23 a share cost basis. Would have to pay short term capital gains if I sell before the EOY.

Aidan Donnelly :

Cheers. Had 300, big jump sold 100 for cost of 300 and just sold the other 200 for 40k profit…… so happy😀

shark91110 :

I shorted it yesterday for quick profit

eugenebong60 :

sounds like you missed out😂😂😂

Константин Кулов :

MRNA is public only 7 years.

J :

As a researcher/ geneticist, this technology is unique and could potentially cure everything. The sky is the limit for this stock

AR 🇪🇺 :

Buy the rumour - sell the news